Starsource Multitrade Limited, formerly Chemo Pharma Laboratories Limited, is an India-based company. The Company was engaged in manufacturing operations. It has no operations and does not generate any revenue. The Company is exploring new business opportunities.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
26-09-11	₹72.75	-1.01%	1
26-09-10	₹73.49	-2.74%	144
26-09-09	₹75.56	-2.79%	3
26-09-08	₹77.73	-1.71%	22

Delayed Quote Bombay S.E.

More quotes

Market Closed - Bombay S.E. 06:03:03 2026-09-11 EDT			5-day change	1st Jan Change
72.75 ^INR	-1.01%		-8.00%	-36.57%

08-14	Starsource Multitrade Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-29	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Market Cap	109M 1.14M 985K 932K 844K 1.58M 1.6M 11.12M 4.28M 55.33M 4.27M 4.18M 176M	P/E 2025	54.6x	P/E 2026	-1.41x
Enterprise Value	95.96M 1M 867K 819K 742K 1.39M 1.4M 9.78M 3.76M 48.66M 3.76M 3.67M 155M	EV / Sales 2025	13x	EV / Sales 2026	28x
Free-Float	61.17%	Yield 2025 *	-	Yield 2026	-

08-14	Starsource Multitrade Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-29	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-12	Starsource Multitrade Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-13	Starsource Multitrade Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-10-01	Chemo Pharma Laboratories Limited has Changed its Name to Starsource Multitrade Limited	CI
25-09-25	Chemo Pharma Laboratories Limited Announces Changes to Its Board	CI
25-09-25	Chemo Pharma Laboratories Limited Appoints and Regularize Utsav Trivedi as CFO	CI
25-09-25	Chemo Pharma Laboratories Limited Appoints and Regularize Ruchit Mehta as Chief Executive Officer	CI
25-09-12	Chemo Pharma Laboratories Limited Announces Company Secretary and Compliance Officer, Effective from September 12, 2025	CI
25-08-12	Chemo Pharma Laboratories Limited Decides to Shift the Registered Office	CI
25-08-12	Chemo Pharma Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-05-29	Starsource Multitrade Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
25-05-27	Chemo Pharma Laboratories to Open New Corporate Office in Ahmedabad, India; Shares Down 4%	MT

1 day	-1.01%
1 week	-8.00%
Current month	-14.21%
1 month	-19.00%
3 months	-32.95%
6 months	-3.00%
Current year	-36.57%

Starsource Multitrade Limited Stock

Stocks

CHEMOPH6

INE320M01019

Investment Holding Companies

Valuation: Starsource Multitrade Limited

Chart: Starsource Multitrade Limited

Latest news: Starsource Multitrade Limited

Quotes and Performance

Price Extremes

Managers and Directors: Starsource Multitrade Limited

Shell Companies

Financials

Company Profile

Quotes

1 week	72.75	78
1 month	72.75	95
Current year	72	152.9
1 year	72	152.9
3 years	28	154
5 years	22.7	154
10 years	5.45	154

Manager	Title	Age	Since
Ruchit Mehta CEO	Chief Executive Officer	35	2025-04-15
Utsav Trivedi DFI	Director of Finance/CFO	27	2025-04-15
Aditya Agarwal CMP	Compliance Officer	-	2025-09-11

Director	Title	Age	Since
Simran Ankleshwar Tripathi BRD	Director/Board Member	-	2024-12-30
Ruchit Mehta BRD	Director/Board Member	35	2025-04-15
Simran Utsav Trivedi BRD	Director/Board Member	30	2024-12-30

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STARSOURCE MULTITRADE LIMITED	-1.01%	-8.00%	-38.84%	+117.16%	1.14M
CHURCHILL CAPITAL CORP XI	+0.42%	-10.07%	-	-	668M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.10%	0.00%	-	-	648M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.10%	-0.24%	-	-	602M
CANTOR EQUITY PARTNERS IV, INC.	0.00%	-0.34%	+2.02%	-	592M
CENTIEL AG	-1.06%	-3.79%	+242.75%	-77.68%	563M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.27%	-2.10%	-	-	554M
NEW AMERICA ACQUISITION I CORP.	-0.05%	-0.25%	-	-	504M
ARES ACQUISITION CORPORATION III	+0.10%	+0.50%	-	-	499M
Average	-0.23%	-2.66%	+68.64%	+19.74%	514.7M
Weighted average by Cap.	-0.12%	-2.09%	+119.15%	-77.29%

	2025	2026
Net sales	6.2M 64.62K 55.97K 52.93K 47.92K 89.93K 90.61K 632K 243K 3.14M 243K 237K 10.02M	5.5M 57.29K 49.62K 46.92K 42.48K 79.73K 80.33K 560K 215K 2.79M 215K 210K 8.89M
Net income	3.42M 35.67K 30.9K 29.22K 26.45K 49.65K 50.02K 349K 134K 1.74M 134K 131K 5.53M	-119M -1.24M -1.07M -1.01M -916K -1.72M -1.73M -12.08M -4.65M -60.11M -4.64M -4.54M -192M
Net Debt	-106M -1.11M -959K -907K -821K -1.54M -1.55M -10.82M -4.16M -53.86M -4.16M -4.07M -172M	-13.16M -137K -119K -112K -102K -191K -192K -1.34M -516K -6.67M -515K -504K -21.29M